BIOMAT Database Logo BIOMAT Database Logo

Expression of a biologically active diphtheria toxin fragment B in Escherichia coli. 1988

V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
Laboratoire de Chimie Physique des Macromolécules aux Interfaces, Université Libre de Bruxelles, Belgium.

The toxB gene of Corynebacterium diphtheriae bacteriophage beta encoding the B fragment of diphtheria toxin was cloned into an inducible expression vector. When expressed in Escherichia coli, fragment B was not proteolysed and was indistinguishable, by immunological criteria, from wild-type C. diphtheriae-derived fragment B. Soluble fragment B was partially purified from the cytoplasm by saline precipitation steps and was shown to compete with the wild-type diphtheria toxin for binding to receptors of sensitive eukaryotic cells. A complete diphtheria toxin was reconstituted by formation of the disulphide bridge between purified fragment A and recombinant fragment B, which migrates at the expected Mr on Western blots and which was able to block protein synthesis by ADP-ribosylation of elongation factor-2, thereby indicating that the recombinant fragment B had retained its biological activity.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003353 Corynebacterium diphtheriae A species of gram-positive, asporogenous bacteria in which three cultural types are recognized. These types (gravis, intermedius, and mitis) were originally given in accordance with the clinical severity of the cases from which the different strains were most frequently isolated. This species is the causative agent of DIPHTHERIA.
D004167 Diphtheria Toxin An ADP-ribosylating polypeptide produced by CORYNEBACTERIUM DIPHTHERIAE that causes the signs and symptoms of DIPHTHERIA. It can be broken into two unequal domains: the smaller, catalytic A domain is the lethal moiety and contains MONO(ADP-RIBOSE) TRANSFERASES which transfers ADP RIBOSE to PEPTIDE ELONGATION FACTOR 2 thereby inhibiting protein synthesis; and the larger B domain that is needed for entry into cells. Corynebacterium Diphtheriae Toxin,Toxin, Corynebacterium Diphtheriae
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial

Related Publications

V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
The preparation of stable, biologically active B fragment of diphtheria toxin.
August 1976, Biochemical and biophysical research communications,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
The expression of biologically active cholera toxin in Escherichia coli.
August 1982, Nucleic acids research,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
The expression of biologically active cholera toxin in Escherichia coli.
January 1983, Developments in biological standardization,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
High-level expression of a proteolytically sensitive diphtheria toxin fragment in Escherichia coli.
November 1987, Journal of bacteriology,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines.
January 2022, Clinical and experimental vaccine research,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
Cloning and expression in Escherichia coli of three fragments of diphtheria toxin truncated within fragment B.
April 1987, Journal of bacteriology,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
Diphtheria toxin expression in Escherichia coli.
January 1992, Targeted diagnosis and therapy,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
Expression of a biologically active fragment of human IgE epsilon chain in Escherichia coli.
September 1984, Proceedings of the National Academy of Sciences of the United States of America,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
Expression of a biologically-active conotoxin PrIIIE in Escherichia coli.
March 2012, Protein expression and purification,
V Cabiaux, and A Phalipon, and R Wattiez, and P Falmagne, and J M Ruysschaert, and M Kaczorek
Renaturated ricin toxin B chain made in Escherichia coli is soluble, stable, and biologically active.
April 1994, Biochemistry and molecular biology international,
Copied contents to your clipboard!